NCT06204120View on ClinicalTrials.gov

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

July 4, 2023

Study Completion Date

July 4, 2023

Conditions
Pain, Postoperative
Interventions
DRUG

LPM3480392 Injection

PCA administration

DRUG

Placebo

PCA administration

DRUG

morphine hydrochloride injection

PCA administration

Trial Locations (1)

430022

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY